CellGenix GmbH starts work on cell therapy regent facility expansion

By Gareth Macdonald contact

- Last updated on GMT

iStock/luchschen
iStock/luchschen

Related tags: Gene, Dna

CellGenix GmbH has started expanding its cell and gene therapy reagents facility in Freiburg, Germany citing the progression of customer projects into clinical development and commercial launch.

The firm will add a research and development laboratory and well as production and warehouse space at the facility. It will also install large-scale filling capacity for therapeutic recombinant proteins.

CellGenix expects the expansion project to be completed early next year. The firm also said it plans to hire staff with experience in R&D, quality control and production.

The firm cited the progression of customer projects as well as a general increase in market demand for good manufacturing practice (GMP) grade raw materials as the driver for the investment.

CEO Felicia Rosenthal said: “The investment we are making is a very positive sign for the gene and cell therapy space and the future of CellGenix. It will allow us to fulfill the increasing demand for GMP-grade cytokines and serum-free media​.”

Reagent demand

CellGenix is only the latest supplier to invest in reagent capacity citing growing demand.

In December, Thermo Fisher bought cell reagents supplier MTI-GlobalStem.

At the time Thermo told us the capacity gained will help customers “accelerate discovery in the development of disease models for drug screening, cells as factories for early development of biological drugs, and cell-based therapies.”

Related news

Show more

Related products

show more

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 22-Jul-2019 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Small-Scale Cell Culture Perfusion Process

Small-Scale Cell Culture Perfusion Process

Eppendorf for Bioprocess – Solutions that grow with you | 29-Mar-2019 | Application Note

Perfusion cell culture processes promise advantages for industrial bioprocessing, like saving space, increasing volumetric productivity, achieving more...

Related suppliers

Follow us

Products

View more

Webinars